SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-010086
Filing Date
2022-03-14
Accepted
2022-03-14 16:18:28
Documents
14
Period of Report
2022-03-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20220314.htm   iXBRL 8-K 41677
2 EX-99.1 life-ex991_8.htm EX-99.1 204610
3 GRAPHIC gav30wrxuxu5000001.jpg GRAPHIC 10916
  Complete submission text file 0001564590-22-010086.txt   404182

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA life-20220314.xsd EX-101.SCH 5701
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20220314_lab.xml EX-101.LAB 19431
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20220314_pre.xml EX-101.PRE 11588
8 EXTRACTED XBRL INSTANCE DOCUMENT life-8k_20220314_htm.xml XML 3552
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 22736817
SIC: 2836 Biological Products, (No Diagnostic Substances)